# IGC Pharma, Inc.: Form 8-K, filed Nov 2, 2018

- Company: [IGC Pharma, Inc.](/companies/igc.md) (CIK 1326205)
- Form: 8-K
- Filed: 2018-11-02
- Accepted by EDGAR: Nov 1, 2018, 19:16 ET
- Period: 2018-10-29
- Accession: 0001185185-18-001897
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1326205/000118518518001897/indiaglob20181101_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326205/000118518518001897/

## Items reported

- Item 3.01: Delisting notice
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326205/000118518518001897/indiaglob20181101_8k.htm

Filed Nov 2, 2018.
Source: SEC EDGAR, the filing index for accession 0001185185-18-001897. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.
